The Circuit Court today confirmed a scheme of arrangement for biotech start-up Senoptica based on an investment proposal from company creditors, despite misgivings from some of the co-founders, who appeared in court to put their concerns “on the public record”. The company, spun out of TCD in 2018, develops food-sensor technology to monitor the condition of packaged food. The court was told that the company has intellectual property that “everyone agrees is very valuable”. Senoptica went into examinership last year at the instigation of creditors. It was an unusual move that was prompted by a stand-off between management and creditors…

Want to continue reading?

Join today and get full access to The Currency and The Wall Street Journal – TWO premium memberships for the price of one.

Subscribe

Cancel at any time.

Are you already a member? .